ZHOU, D., LIANG, J., XU, L., HE, F., ZHOU, Z., ZHANG, Y., & CHEN, M. (2016). Derived neutrophil to lymphocyte ratio predicts prognosis for patients with HBV-associated hepatocellular carcinoma following transarterial chemoembolization. Oncol Lett.

ZHOU, DONGSHENG, JIANZHONG LIANG, LI XU, FENGYING HE, ZHONGGUO ZHOU, YAOJUN ZHANG, and MINSHAN CHEN. "Derived Neutrophil to Lymphocyte Ratio Predicts Prognosis for Patients With HBV-associated Hepatocellular Carcinoma Following Transarterial Chemoembolization." Oncol Lett 2016.

ZHOU, DONGSHENG, et al. "Derived Neutrophil to Lymphocyte Ratio Predicts Prognosis for Patients With HBV-associated Hepatocellular Carcinoma Following Transarterial Chemoembolization." Oncol Lett 2016.